In total agreement, Ig. Having said that, these manipulating aholes have entirely destroyed any belief I had that biotechs with solid science can eventually overcome market manipulation through incremental progress, without making a deal with the devil.
For me, this means that after ADXS achieves its long awaited success over the next year or two, most probably through a pretty profitable sale from these levels, I will no longer invest in biotechs for the long term. Swing trading and catalyst trading are the only options I can get behind. It would be a travesty for small cap biotechs if more people came to the same conclusion, if only for a lack of better choices. HFT has now well and truly decimated any semblance of a free market in this country.
News 
Market Data 
Discover 
AI
